drugset / Trial / NCT00763750
PPX, Temozolomide, and Concurrent Radiation for Newly Diagnosed Brain Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the antitumor activity of PPX in combination with temozolomide and radiation for patients with newly diagnosed brain tumors.
Timeline
- Start
- 2008-10
- Primary completion
- 2011-06
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temozolomide | Small molecule | 75 mg/m2 | — |
| Subject | paclitaxel poliglumex | Other / unclassified | 40 mg/m2 | — |
| Subject | paclitaxel poliglumex | Other / unclassified | 50 mg/m2 | — |